Cargando…

Successful Management of Severe Hyperhaemolysis with Combined Tocilizumab and Rituximab in Non-Transfusion-Dependent Thalassaemia: A Case Report

INTRODUCTION: This is the fourth case reporting the administration of tocilizumab to control hyperhaemolysis. It was administered with rituximab to stop hyperhaemolysis refractory to frontline therapy. Hyperhaemolysis is a rare life-threatening subtype of delayed haemolytic transfusion reaction. Ref...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Afifi, Amal M., Saeed, Alia M., Fekry, Gihad H., Mostafa, Mariam A., Elmetwally, Reham A., Hamed, Inas M., Hussein, Aliaa N., Hasanien, Gomaa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911996/ https://www.ncbi.nlm.nih.gov/pubmed/36818772 http://dx.doi.org/10.1159/000524743

Ejemplares similares

The role of tocilizumab in the treatment of post‐transfusion hyperhaemolysis
por: Desai, Naeem, et al.
Publicado: (2023)

Status of Superoxide Dismutase in Transfusion Dependent Thalassaemia
por: Rujito, Lantip, et al.
Publicado: (2015)

When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia
por: Taher, A T, et al.
Publicado: (2015)

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
por: Gavriilaki, Eleni, et al.
Publicado: (2018)

Iron overload across the spectrum of non‐transfusion‐dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
por: Porter, John B., et al.
Publicado: (2016)

Hyperhaemolysis in a pregnant woman with a homozygous β(0)‐thalassemia mutation and two genetic modifiers
por: Jiwu, Lou, et al.
Publicado: (2021)

Factors affecting height in children and adolescents with transfusion-dependent Thalassaemia – results from a Thalassaemia center in Malaysia
por: Ting, Tzer Hwu, et al.
Publicado: (2013)

The heart in transfusion dependent homozygous thalassaemia today – prediction, prevention and management
por: Aessopos, Athanassios, et al.
Publicado: (2008)

Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients
por: Ahmed, Azza Mohamed, et al.
Publicado: (2010)

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Epidemiology of Transfusion Transmitted Infection among Patients with β-Thalassaemia Major in Pakistan
por: Ahmed Kiani, Rizwan, et al.
Publicado: (2016)

Psychiatric disorders and caregiver burden in children with transfusion dependent β-thalassaemia and their caregivers
por: Sahu, Samiksha, et al.
Publicado: (2023)

Experiences, Knowledge Gaps and Information Needs of Women in Australia with Transfusion Dependent Thalassaemia in Regard to Fertility and Pregnancy
por: Matthiesson, Hannah K, et al.
Publicado: (2023)

Thalassaemia Intermedia: an Update
por: Taher, Ali T., et al.
Publicado: (2009)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

Psychological morbidity among children with transfusion dependent β-thalassaemia and their parents in Sri Lanka
por: Mettananda, Sachith, et al.
Publicado: (2020)

Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
por: Subahi, Eihab A., et al.
Publicado: (2022)

Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia
por: Taher, Ali T, et al.
Publicado: (2023)

α-thalassaemia
por: Harteveld, Cornelis L, et al.
Publicado: (2010)

Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study
por: Mettananda, Sachith, et al.
Publicado: (2019)

Prevention of Cardiomyopathy in Transfusion-Dependent Homozygous Thalassaemia Today and the Role of Cardiac Magnetic Resonance Imaging
por: Aessopos, Athanassios, et al.
Publicado: (2009)

Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective
por: Shafie, Asrul Akmal, et al.
Publicado: (2021)

Screening for beta thalassaemia
por: Petrou, Mary
Publicado: (2010)

Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition
por: Viprakasit, Vip, et al.
Publicado: (2014)

Transfusion-Related Acute Lung Injury (TRALI) in two Thalassaemia Patients Caused by the Same Multiparous Blood Donor
por: Kolnagou, Annita, et al.
Publicado: (2017)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia
por: Yasara, Nirmani, et al.
Publicado: (2022)

Quality of life and challenges experienced by the surviving adults with transfusion dependent thalassaemia in Malaysia: a cross sectional study
por: Foong, Wai Cheng, et al.
Publicado: (2022)

Transfusion-transmitted severe Plasmodium knowlesi malaria in a splenectomized patient with beta-thalassaemia major in Sabah, Malaysia: a case report
por: Bird, Elspeth M., et al.
Publicado: (2016)

Vitamin D assessment in patients with COVID-19 virus and correlation with severity
por: Yosef, Tarek M., et al.
Publicado: (2022)

Thalassaemia and Aberrations of Growth and Puberty
por: Kyriakou, Andreas, et al.
Publicado: (2009)

THALASSAEMIA IS A TROPICAL DISEASE
por: Kotila, T.R.
Publicado: (2012)

Red cell alloantibodies in beta-thalassaemia major patients’ blood referring to the regional blood transfusion center of Tehran, Iran
por: Ebrahimisadr, Parisa, et al.
Publicado: (2021)

Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry
por: Mohd Ibrahim, Hishamshah, et al.
Publicado: (2020)

Oxidative stress in β-thalassaemia and sickle cell disease
por: Voskou, S., et al.
Publicado: (2015)

Beta-Thalassaemia Intermedia: Evaluation of Endocrine and Bone Complications
por: Baldini, M., et al.
Publicado: (2014)

Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial
por: Yasara, Nirmani, et al.
Publicado: (2020)

Transfusion-induced Plasmodium falciparum malaria in a beta thalassaemia patient during the prevention of re-establishment phase in Sri Lanka
por: Chulasiri, Pubudu, et al.
Publicado: (2021)

Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study
por: Medina, Katia Menacho, et al.
Publicado: (2021)

Osteoporosis Syndrome in Thalassaemia Major: An Overview
por: Toumba, Meropi, et al.
Publicado: (2010)

Endocrine complications in patients with thalassaemia major
por: Meng, Zhe, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iu0n2b0b0o9bv35l98f9pt3r58